Showing posts with label paper. Show all posts
Showing posts with label paper. Show all posts

Thursday, 3 January 2019

Teenagers Diagnosed With Attention Deficit Hyperactivity Disorder

Teenagers Diagnosed With Attention Deficit Hyperactivity Disorder.
Some colonize denominate it "brain doping" or "meducation". Others label the problem "neuroenhancement". Whatever the term, the American Academy of Neurology has published a placement paper criticizing the practice of prescribing "study drugs" to encouragement memory and thinking abilities in healthy children and teens. The authors said physicians are prescribing drugs that are typically reach-me-down for children and teenagers diagnosed with attention-deficit/hyperactivity scuffle (ADHD) for students solely to improve their ability to ace a critical exam - such as the college affirmation SAT - or to get better grades in school.

Dr William Graf, lead father of the paper and a professor of pediatrics and neurology at Yale School of Medicine, emphasized that the statement doesn't put in to the appropriate diagnosis and treatment of ADHD. Rather, he is concerned about what he calls "neuroenhancement in the classroom". The delinquent is similar to that caused by performance-boosting drugs that have been used in sports by such athletic luminaries as Lance Armstrong and Mark McGwire.

So "One is about enhancing muscles and the other is about enhancing brains". In children and teens, the use of drugs to get better unrealistic performance raises issues including the dormant long-term effect of medications on the developing brain, the distinction between normal and abnormal intellectual development, the grill of whether it is ethical for parents to force their children to take drugs just to improve their academic performance, and the risks of overmedication and chemical dependency.

The speedily rising numbers of children and teens taking ADHD drugs calls limelight to the problem. "The number of physician office visits for ADHD running and the number of prescriptions for stimulants and psychotropic medications for children and adolescents has increased 10-fold in the US over the survive 20 years," he pointed out.